Schizophrenogensis is the title of Damien Hirst's latest exhibition, currently on display in London's Paul Stolper Gallery.
This is not Hirst's first project to explore the pharmaceutical industry. Previrously, Hirst designed the Cathedral Collection, a jewelry collection in which every piece was shaped in the form of pills. Because what's more glamorous than a diamond-encrusted cluster of Vicodin?
This installation is a little less compact that those pieces, featuring life-size replicas of pills, pill boxes and syringes. Those who are interested in decorating their homes with pharmaceutical art will be delighted to know that prints and sculpture versions of Hirst's work is available for purchase. While I can't explain the British designer's fixation on drug dependency and mental illness, his pieces are nonetheless incredibly thought-provoking.
What's Driving This Trend
- Pharmaceutical Art
- Exploring the intersection of art and the pharmaceutical industry, providing an innovative platform for creativity and discussion.
- Mental Health Awareness
- Raising awareness and destigmatizing mental illness through artistic expression and immersive installations.
- Consumer Art Purchases
- Offering consumers the opportunity to own unique pharmaceutical-inspired art pieces for their homes and collections.
Who This Affects Most
- Art
- Creating new opportunities for artists to express their creativity through unconventional themes and mediums.
- Pharmaceutical
- Inspiring potential collaborations and innovations between the pharmaceutical and art industries.
- Fashion and Luxury
- Exploring potential for artistic designs and collaborations within the fashion and luxury industries using pharmaceutical motifs.
